SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-064438
Filing Date
2012-12-13
Accepted
2012-12-13 15:30:43
Documents
1
Period of Report
2012-12-12

Document Format Files

Seq Description Document Type Size
1 rrd363472.html 4  
1 rrd363472.xml 4 12427
  Complete submission text file 0001181431-12-064438.txt   13729
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Issuer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850
Business Address
Martin Tami Tillotson (Reporting) CIK: 0001539494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 121262044